Activation of Cytosolic Cathepsin B Activity in the Brain by Traumatic Brain Injury and Inhibition by the Neutral pH Selective Inhibitor Probe Z-Arg-Lys-AOMK
ACS Chemical Neuroscience · 2025
DOI: 10.1021/acschemneuro.4c00577 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, 2025. Verfasst von Sonia Podvin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California 92093, United States. Hauptthemen laut MEDLINE: Cathepsin B, Brain Injuries, Traumatic, Cytosol, Brain. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Cathepsin B has been shown to contribute to deficits in traumatic brain injury (TBI), an important risk factor for Alzheimer's disease (AD). Cathepsin B is elevated in TBI and AD patients, as well as in animal models of these conditions. Knockout of the cathepsin B gene results in amelioration of TBI-induced motor dysfunction and improvement of AD memory deficit in mice. The mechanism of cathepsin B pathogenesis in these brain disorders has been hypothesized to involve its translocation to the cytosol from its normal lysosomal location. This study, therefore, evaluated brain cytosolic cathepsin B activity in the controlled cortical impact (CCI) mouse model of TBI. CCI-TBI resulted in motor deficits demonstrated by the rotarod assay, brain tissue lesions, and disorganization of the hippocampus. Significantly, CCI-TBI increased cytosolic cathepsin B activity in the brain cortex in the ipsilateral brain hemisphere that received the CCI-TBI injury, with a concomitant decrease in the lysosomal fraction. Cathepsin B activity was monitored using the substrate Z-Nle-Lys-Arg-AMC which specifically detects cathepsin B activity but not other cysteine proteases. The normal lysosomal distribution of cathepsin B was observed by its discrete localization in brain cortical cells. CCI-TBI resulted in a more diffuse cellular distribution of cathepsin B consistent with translocation to the cytosol. Further studies utilized the novel neutral pH-selective inhibitor, Z-Arg-Lys-AOMK, that specifically inhibits cathepsin B at neutral pH 7.2 of the cytosol but not at acidic pH 4.6 of lysosomes. Daily administration of Z-Arg-Lys-AOMK (ip), beginning 1 day before CCI-TBI, resulted in the reduction of the increased cytosolic cathepsin B activity induced by CCI-TBI. The inhibitor also reduced cathepsin B activities in homogenates of the brain cortex and hippocampus which were increased by CCI-TBI. Furthermore, the Z-Arg-Lys-AOMK inhibitor resulted in the reduction of motor function deficit resulting from CCI-TBI. These findings demonstrate the activation of cytosolic cathepsin B activity in CCI-TBI mouse brain injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, California 92093, United States.
- Department of Physiology and Neuroscience, USC Alzheimer's Therapeutic Research Institute, 9880 Mesa Rim Road, San Diego, California 92121, United States.
- Biomedical Sciences Graduate Program, University of California, San Diego, La Jolla, California 92093, United States.
- Center for Marine Biotechnology and Biomedicine, Scripps Institution of Oceanography, University of California, San Diego, La Jolla, California 92093, United States.
- Department Pharmaceutical Sciences, College of Pharmacy, The University of Jordan, Amman 11942, Jordan.
- Department of Neurosciences and Department of Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California 92093, United States.
ORCID-Profile: Michael C Yoon, William H Gerwick, Vivian Hook
Förderung
- NIA NIH HHS
- NINDS NIH HHS
- NIGMS NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
- National Institute of General Medical Sciences
Zitieren
APA
Podvin, S., Florio, J., Spencer, B., Mante, M., Guzman, E., Arias, C., Mosier, C., Phan, V. V., Yoon, M. C., Almaliti, J., O'Donoghue, A. J., Gerwick, W. H., Rissman, R. A., & Hook, V. (2025). Activation of Cytosolic Cathepsin B Activity in the Brain by Traumatic Brain Injury and Inhibition by the Neutral pH Selective Inhibitor Probe Z-Arg-Lys-AOMK. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.4c00577
Vancouver
Podvin S, Florio J, Spencer B, Mante M, Guzman E, Arias C, et al. Activation of Cytosolic Cathepsin B Activity in the Brain by Traumatic Brain Injury and Inhibition by the Neutral pH Selective Inhibitor Probe Z-Arg-Lys-AOMK. ACS Chemical Neuroscience. 2025. doi:10.1021/acschemneuro.4c00577
BibTeX
@article{Podvin2025,
author = {Podvin, Sonia and Florio, Jazmin and Spencer, Brian and Mante, Michael and Guzman, Estefani and Arias, Carlos and Mosier, Charles and Phan, Von V and Yoon, Michael C and Almaliti, Jehad and O'Donoghue, Anthony J and Gerwick, William H and Rissman, Robert A and Hook, Vivian},
title = {Activation of Cytosolic Cathepsin B Activity in the Brain by Traumatic Brain Injury and Inhibition by the Neutral pH Selective Inhibitor Probe Z-Arg-Lys-AOMK},
journal = {ACS Chemical Neuroscience},
year = {2025},
doi = {10.1021/acschemneuro.4c00577}
}
EUVIMED